On the recordNovember 17, 2011
few things are more important to consumer well being than ensuring the safety of our pharmaceutical supply chain. Yet today, the penalties for counterfeit drug offenses are outdated and insufficient to deter this epidemic problem. As a result, counterfeit medicines reportedly lead to 100,000 deaths globally each year, with upwards of 90 percent of drug sales estimated to be counterfeit. Similarly, few things are more important to the American economy and long-term job creation than protecting our companies' intellectual property. Yet businesses manufacturing and selling counterfeit drugs reportedly generate more than $75 billion in annual revenue. This means lost profits for American businesses and lost jobs for American workers. Such staggering numbers would be unacceptable in any economic climate, and they are devastating today. Combating the sale of counterfeit drugs is increasingly difficult. Whether it is the prevalence of Internet pharmacies, or the new and sophisticated methods of manufacturing, packaging and distributing counterfeit drugs, the obstacles to safeguarding the pharmaceutical supply chain in today's economy are many. As a result, large counterfeit drug enterprises are being funded on the backs of consumers, both in Vermont and around the country, whose health and safety are at stake.…





